263 related articles for article (PubMed ID: 17258939)
1. Immunoblotting on HEp-2 cells increases the detection of antitopoisomerase 1 antibodies in patients with systemic sclerosis.
Tamby MC; Servettaz A; Guilpain P; Tamas N; Berezné A; Batteux F; Reinbolt J; Guillevin L; Weill B; Mouthon L
Clin Immunol; 2007 Apr; 123(1):82-8. PubMed ID: 17258939
[TBL] [Abstract][Full Text] [Related]
2. A case of systemic sclerosis with anticentromere, antitopoisomerase I, and anti-U1RNP antibodies.
Sato S; Ihn H; Soma Y; Shimozuma M; Shishiba T; Takehara K
J Rheumatol; 1993 Nov; 20(11):1961-3. PubMed ID: 8308786
[TBL] [Abstract][Full Text] [Related]
3. Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis.
Hénault J; Tremblay M; Clément I; Raymond Y; Senécal JL
Arthritis Rheum; 2004 Oct; 50(10):3265-74. PubMed ID: 15476238
[TBL] [Abstract][Full Text] [Related]
4. Anticentromere autoantibodies in patients without Raynaud's disease or systemic sclerosis.
Vázquez-Abad D; Grodzicky T; Senécal JL
Clin Immunol; 1999 Feb; 90(2):182-9. PubMed ID: 10080829
[TBL] [Abstract][Full Text] [Related]
5. Anti-topoisomerase-I and clinical findings in systemic sclerosis (scleroderma).
Shoenfeld Y; Grunebaum E; Laufer M; Zurgil N; Bakimer R; Lunderschmidt A; Valentini G; Tirri G; Blank M
Isr J Med Sci; 1996 Jul; 32(7):537-42. PubMed ID: 8756980
[TBL] [Abstract][Full Text] [Related]
6. Antitopoisomerase and anticentromere antibodies in the sclerodermatosus complex.
Kallenberg CG
Clin Rev Allergy; 1994; 12(3):221-35. PubMed ID: 7804956
[No Abstract] [Full Text] [Related]
7. Antikinetochore and antitopoisomerase I antibodies in systemic scleroderma: comparative study using immunoblotted recombinant antigens, immunofluorescence, and double immunodiffusion.
Jarzabek-Chorzelska M; Blaszczyk M; Kolacinska-Strasz Z; Chorzelski T; Jabłońska S; Maul GG
Arch Dermatol Res; 1990; 282(2):76-83. PubMed ID: 2162156
[TBL] [Abstract][Full Text] [Related]
8. IgG reactivity with a 100-kDa tissue and endothelial cell antigen identified as topoisomerase 1 distinguishes between limited and diffuse systemic sclerosis patients.
García de la Peña-Lefebvre P; Chanseaud Y; Tamby MC; Reinbolt J; Batteux F; Allanore Y; Kahan A; Meyer O; Benveniste O; Boyer O; Guillevin L; Boissier MC; Mouthon L
Clin Immunol; 2004 Jun; 111(3):241-51. PubMed ID: 15183145
[TBL] [Abstract][Full Text] [Related]
9. Specificity of anti-Scl-70 antibodies in scleroderma: increased sensitivity of detection using purified DNA topoisomerase I from calf thymus.
Tsay GJ; Fann RH; Hwang J
J Rheumatol; 1990 Oct; 17(10):1314-9. PubMed ID: 2174971
[TBL] [Abstract][Full Text] [Related]
10. Analysis of IgG subclasses of human antitopoisomerase I autoantibodies suggests chronic B cell stimulation.
Vázquez-Abad D; Monteón V; Senécal JL; Walsh S; Rothfield N
Clin Immunol Immunopathol; 1997 Jul; 84(1):65-72. PubMed ID: 9191885
[TBL] [Abstract][Full Text] [Related]
11. Anti-DNA topoisomerase II alpha autoantibodies in Japanese patients with systemic sclerosis.
Hayakawa I; Hasegawa M; Takehara K; Sato S
Arch Dermatol Res; 2005 Oct; 297(4):180-3. PubMed ID: 16180014
[TBL] [Abstract][Full Text] [Related]
12. DNA topoisomerase I binding to fibroblasts induces monocyte adhesion and activation in the presence of anti-topoisomerase I autoantibodies from systemic sclerosis patients.
Hénault J; Robitaille G; Senécal JL; Raymond Y
Arthritis Rheum; 2006 Mar; 54(3):963-73. PubMed ID: 16508979
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens.
Damoiseaux J; Boesten K; Giesen J; Austen J; Tervaert JW
Ann N Y Acad Sci; 2005 Jun; 1050():340-7. PubMed ID: 16014550
[TBL] [Abstract][Full Text] [Related]
14. Coexistence of antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis.
Dick T; Mierau R; Bartz-Bazzanella P; Alavi M; Stoyanova-Scholz M; Kindler J; Genth E
Ann Rheum Dis; 2002 Feb; 61(2):121-7. PubMed ID: 11796397
[TBL] [Abstract][Full Text] [Related]
15. Immunological markers of the subsets of systemic scleroderma and its overlap.
Jabłońska S; Błaszczyk M; Jarzabek-Chorzelska M; Chorzelski T; Kołacińska-Strasz Z
Arch Immunol Ther Exp (Warsz); 1991; 39(4):381-90. PubMed ID: 1821614
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of three methods for the detection of anti-SCL70 autoantibodies].
Yalaoui S; Gorgi Y; Ayed K
Ann Biol Clin (Paris); 2001; 59(5):639-42. PubMed ID: 11602398
[No Abstract] [Full Text] [Related]
17. Anticentromere antibodies in rheumatologic practice are not consistently associated with scleroderma.
Tubach F; Hayem G; Elias A; Nicaise P; Haim T; Kahn MF; Meyer O
Rev Rhum Engl Ed; 1997 Jun; 64(6):362-7. PubMed ID: 9513607
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal study of anticentromere and antitopoisomerase-I isotypes.
Vázquez-Abad D; Russell CA; Cusick SM; Earnshaw WC; Rothfield NF
Clin Immunol Immunopathol; 1995 Mar; 74(3):257-70. PubMed ID: 7859416
[TBL] [Abstract][Full Text] [Related]
19. [Anti-idiotypic antibodies to topoisomerase I in serum from patients with autoimmune diseases].
Bronshteĭn IB; Shuster AM; Gromova II; Krashuk OA; Geva ON; Alekberova ZS; Gabibov AG
Dokl Akad Nauk SSSR; 1991; 318(6):1496-500. PubMed ID: 1655373
[No Abstract] [Full Text] [Related]
20. Anti-DNA topoisomerase IIalpha autoantibodies in localized scleroderma.
Hayakawa I; Hasegawa M; Takehara K; Sato S
Arthritis Rheum; 2004 Jan; 50(1):227-32. PubMed ID: 14730620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]